The demand for Sensory Organ Drugs in BRICS countries has been steadily increasing over the years, driven by a growing aging population and rising prevalence of sensory organ-related disorders.
Customer preferences: Patients in BRICS countries are increasingly seeking out sensory organ drugs that offer effective treatment for various eye and ear disorders. The demand for drugs that can treat age-related macular degeneration, glaucoma, cataracts, and hearing loss has been on the rise. Patients are also looking for drugs that are affordable, easily accessible, and have minimal side effects.
Trends in the market: Brazil has emerged as the largest market for sensory organ drugs in the BRICS region, driven by a growing elderly population and rising prevalence of age-related macular degeneration and glaucoma. Russia is also witnessing a rise in demand for sensory organ drugs due to a high incidence of hearing loss and eye disorders. China and India are the fastest-growing markets, driven by increasing healthcare spending and a rising middle class population. In China, there is a growing demand for innovative drugs that can effectively treat eye disorders, while in India, there is a demand for affordable drugs that can treat a wide range of eye and ear disorders.
Local special circumstances: In Brazil, the government's efforts to expand access to healthcare and improve the quality of care have led to an increase in demand for sensory organ drugs. In Russia, the government's focus on improving healthcare infrastructure and increasing healthcare spending has led to a rise in demand for sensory organ drugs. In China, the government's push towards innovation and the development of new drugs has led to a growing demand for innovative sensory organ drugs. In India, the government's focus on expanding access to healthcare and increasing affordability has led to a rise in demand for affordable sensory organ drugs.
Underlying macroeconomic factors: The rising prevalence of sensory organ-related disorders in the BRICS region can be attributed to several underlying macroeconomic factors, including a growing aging population, increasing urbanization, and changing lifestyle habits. Rising healthcare spending, expanding healthcare infrastructure, and increasing government initiatives to improve healthcare access and affordability are also contributing to the growth of the sensory organ drugs market in BRICS countries. Additionally, the growing middle class population and increasing disposable incomes are driving demand for innovative and affordable sensory organ drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
